Liyu He
Impact in
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Renal Diseases and Glomerulopathies
- Dialysis and Renal Disease Management
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
Papers in
- Nephrology 60
- Renal Diseases and Glomerulopathies 35
- Chronic Kidney Disease and Diabetes 19
- Dialysis and Renal Disease Management 13
- Acute Kidney Injury Research 9
- Co-authors
- Zheng Dong (11 shared papers)Chengyuan Tang (19 shared papers)Fuyou Liu (24 shared papers)Youming Peng (32 shared papers)Hong Liu (32 shared papers)Lin Sun (17 shared papers)Xiaofei Peng (25 shared papers)Yu Liu (6 shared papers)
- Journals
- American Journal of Nephrology (7 papers)Renal Failure (6 papers)Pharmacology (4 papers)Frontiers in Endocrinology (4 papers)Current Medicinal Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Liyu He
87 papers receiving 3.0k citations
Liyu He's Hit Papers
Peers
Comparison fields: 5 of 120
- Nephrology 1.2k
- Clinical Biochemistry 300
- Pathology and Forensic Medicine 372
- Molecular Biology 1.3k
- Epidemiology 614
Countries citing papers authored by Liyu He
This map shows the geographic impact of Liyu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyu He more than expected).
Fields of papers citing papers by Liyu He
This network shows the impact of papers produced by Liyu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyu He. The network helps show where Liyu He may publish in the future.
Co-authors
The 25 scholars most cited alongside Liyu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1 Hit paper breakdown → | 2016 | 456 |
| 2 | AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms Hit paper breakdown → | 2017 | 322 |
| 3 | 2017 | 243 | |
| 4 | 2019 | 168 | |
| 5 | 2015 | 150 | |
| 6 | 2015 | 142 | |
| 7 | 2014 | 85 | |
| 8 | 2015 | 74 | |
| 9 | 2014 | 72 | |
| 10 | 2018 | 61 | |
| 11 | 2014 | 60 | |
| 12 | 2020 | 60 | |
| 13 | 2020 | 59 | |
| 14 | 2015 | 45 | |
| 15 | 2018 | 44 | |
| 16 | 2023 | 43 | |
| 17 | 2015 | 38 | |
| 18 | 2015 | 38 | |
| 19 | 2012 | 37 | |
| 20 | 2019 | 37 |
About Liyu He
Liyu He is a scholar working on Nephrology, Molecular Biology, Epidemiology, Immunology and Pathology and Forensic Medicine, having authored 93 papers that have together received 3.1k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (35 papers), Chronic Kidney Disease and Diabetes (19 papers), Dialysis and Renal Disease Management (13 papers), Acute Kidney Injury Research (9 papers), Autophagy in Disease and Therapy (8 papers), Autoimmune Bullous Skin Diseases (6 papers), Platelet Disorders and Treatments (6 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Nephrology (1.2k citations), Clinical Biochemistry (300 citations), Pathology and Forensic Medicine (372 citations), Molecular Biology (1.3k citations) and Epidemiology (614 citations). Liyu He has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Zheng Dong, Chengyuan Tang, Fuyou Liu, Youming Peng, Hong Liu, Lin Sun, Xiaofei Peng, Yu Liu, Guoyong Liu and Zhiwen Liu. Their work appears in journals such as American Journal of Nephrology, Renal Failure, Pharmacology, Frontiers in Endocrinology and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.